AN2 THERAPEUTICS INC (ANTX:NASDAQ)
$4.75 0.3 (6.7416%)
Analysed AN2 THERAPEUTICS INC (ANTX:NASDAQ) News Sources
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
12-01-2026
yahoo.com
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference
17-02-2026
yahoo.com
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)
03-03-2026
yahoo.com
AN2 Therapeutics Announces $40 Million Private Placement Financing
09-03-2026
yahoo.com
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
17-03-2026
yahoo.com
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease
31-03-2026
yahoo.com
AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
07-05-2026
yahoo.com
AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights
11-05-2026
yahoo.com
AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
21-05-2026
yahoo.com
AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease
04-06-2026
yahoo.com
What is the current price of AN2 THERAPEUTICS INC (ANTX:NASDAQ)?
The current price of AN2 THERAPEUTICS INC (ANTX:NASDAQ) is $4.75.
AN2 THERAPEUTICS INC (ANTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AN2 THERAPEUTICS INC (ANTX:NASDAQ) since the previous trading day is $0.3.
AN2 THERAPEUTICS INC (ANTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AN2 THERAPEUTICS INC (ANTX:NASDAQ) since the previous trading day is 6.7416%.
What is the most recent average sentiment score for AN2 THERAPEUTICS INC (ANTX:NASDAQ)?
The most recent average sentiment score for AN2 THERAPEUTICS INC (ANTX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for AN2 THERAPEUTICS INC (ANTX:NASDAQ)?
The most recent sentiment for AN2 THERAPEUTICS INC (ANTX:NASDAQ) is .
SEC-8K** Filing Available For AN2 THERAPEUTICS INC (ANTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.